3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Sponsor
Conditions
Neuroblastoma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Ganglioneuroblastoma
3
Burkitt Lymphoma
3
Urinary Bladder Neoplasms
2
Rhabdomyosarcoma, Embryonal
2
Rhabdomyosarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Biphenotypic, Acute
2
Breast Neoplasms
2
Teratoma
1
Squamous Cell Carcinoma of Head and Neck
1
Rhabdomyosarcoma, Alveolar
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms, Germ Cell and Embryonal
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Lymphoma, T-Cell
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lung Neoplasms
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Interventions
Specimen Handling
2
Early Intervention, Educational
2
pertuzumab
1
pembrolizumab
1
X-Ray Therapy
1
Trastuzumab
1
Taxes
1
Surgical Procedures, Operative
1
Standard of Care
1
Protons
1
Proton Therapy
1
Practice Guidelines as Topic
1
Paclitaxel
1
Motivational Interviewing
1
Methods
1
Metformin
1
Magnetic Resonance Spectroscopy
1
High-Energy Shock Waves
1
Educational Status
1
Doxorubicin
1
Docetaxel
1
Cyclophosphamide
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Phase 3
×
Anatomic Stage I Breast Cancer AJCC v8
×
Biopsy
×
Clear all
No trials found.